Login
Butterfly Network Inc logo

Butterfly Network Inc

butterflynetwork.com

Butterfly Network Inc (NYSE: BFLY) is a medical device company that designs and sells handheld, whole-body ultrasound systems built on its proprietary Ultrasound-on-Chip semiconductor platform. Revenue comes from hardware sales of its portable ultrasound probes and recurring software subscriptions, with additional income from professional services and intellectual property licensing to third-party co-development partners. The company sells into the point-of-care ultrasound (POCUS) market, competing against traditional cart-based ultrasound manufacturers and newer handheld device makers. Butterfly reported total revenue of $97.6 million for the year ended December 31, 2025, up from $82.1 million for the year ended December 31, 2024, while incurring net losses of $77.1 million and $72.5 million in those same periods. The company has over 145,000 unique users as of the filing date. It sells through a direct sales force, distributors, and an eCommerce channel to healthcare systems, physicians, and healthcare providers. Headquarters are in the United States.

Products & Services

Butterfly iQ3 (third-generation, launched 2024), Butterfly iQ+ (second-generation), Butterfly iQ+ Bladder, Butterfly Move, Butterfly iQ+/iQ3 Vet devices; cloud-based software subscriptions; Compass AI software for health system integration; Butterfly Garden SDK for third-party AI development; Butterfly Academy educational software; Butterfly Certified courses; ScanLab education app; teleguidance services; professional services for enterprise deployments; Butterfly Embedded co-development licensing.

Revenue Model

Hardware sales of handheld ultrasound probes (Butterfly iQ+ and iQ3), recurring cloud-based software subscriptions, professional services for large-scale deployments, and IP licensing fees from co-development partners under the Butterfly Embedded program.

Customers & Markets

Healthcare systems, hospitals, physicians, and healthcare providers; medical schools; veterinary market; global conflict zone and rural clinic settings. Customers access products via direct sales force, distributors, and eCommerce.

Geographic Exposure

The filing does not provide a specific geographic revenue breakdown. The company references sales to large healthcare systems, rural clinics, and global conflict zones, indicating an international presence.

Financial Snapshot

Revenue
TTM
$112.1M
Gross Margin
TTM
47.55%
Net Income
TTM
-$74.96M
Current Assets
2026 Q2
Current Liabilities
2026 Q2
Current Ratio
2026 Q2
406.03%
Total Assets
2026 Q2
Total Liabilities
2026 Q2
Book Value
2026 Q2
$189.4M
Cash
2026 Q2
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$10.80M

Stock Price

Loading...
Market Cap: $1.8576 Billion

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support